These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 24868471)

  • 1. Targeting interleukin-4 receptor alpha by hybrid Peptide for novel biliary tract cancer therapy.
    Seto K; Shoda J; Horibe T; Warabi E; Kohno M; Yanagawa T; Bukawa H; Nakanuma Y; Kawakami K
    Int J Hepatol; 2014; 2014():584650. PubMed ID: 24868471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-4 receptor α-based hybrid peptide effectively induces antitumor activity in head and neck squamous cell carcinoma.
    Seto K; Shoda J; Horibe T; Warabi E; Ishige K; Yamagata K; Kohno M; Yanagawa T; Bukawa H; Kawakami K
    Oncol Rep; 2013 Jun; 29(6):2147-53. PubMed ID: 23563734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting interleukin-4 receptor α with hybrid peptide for effective cancer therapy.
    Yang L; Horibe T; Kohno M; Haramoto M; Ohara K; Puri RK; Kawakami K
    Mol Cancer Ther; 2012 Jan; 11(1):235-43. PubMed ID: 22084165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel interleukin-13 receptor alpha 2-targeted hybrid peptide for effective glioblastoma therapy.
    Kurihara R; Horibe T; Shimizu E; Torisawa A; Gaowa A; Kohno M; Kawakami K
    Chem Biol Drug Des; 2019 Jul; 94(1):1402-1413. PubMed ID: 30903640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel transferrin receptor-targeted hybrid peptide disintegrates cancer cell membrane to induce rapid killing of cancer cells.
    Kawamoto M; Horibe T; Kohno M; Kawakami K
    BMC Cancer; 2011 Aug; 11():359. PubMed ID: 21849092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2-targeted hybrid peptide that blocks HER2 tyrosine kinase disintegrates cancer cell membrane and inhibits tumor growth in vivo.
    Kawamoto M; Horibe T; Kohno M; Kawakami K
    Mol Cancer Ther; 2013 Apr; 12(4):384-93. PubMed ID: 23358664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting of the Interleukin-13 Receptor (IL-13R)α2 Expressing Prostate Cancer by a Novel Hybrid Lytic Peptide.
    Jannoo R; Xia Z; Row PE; Kanamarlapudi V
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of Tumor Growth against Chemoresistant Cholangiocarcinoma by a Proapoptotic Peptide Targeting Interleukin-4 Receptor.
    Permpoon U; Khan F; Vadevoo SMP; Gurung S; Gunassekaran GR; Kim MJ; Kim SH; Thuwajit P; Lee B
    Mol Pharm; 2020 Nov; 17(11):4077-4088. PubMed ID: 32881535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.
    Kawakami M; Kawakami K; Stepensky VA; Maki RA; Robin H; Muller W; Husain SR; Puri RK
    Clin Cancer Res; 2002 Nov; 8(11):3503-11. PubMed ID: 12429641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Semaphorin 3A lytic hybrid peptide binding to neuropilin-1 as a novel anti-cancer agent in pancreatic cancer.
    Ueyama H; Horibe T; Nakajima O; Ohara K; Kohno M; Kawakami K
    Biochem Biophys Res Commun; 2011 Oct; 414(1):60-6. PubMed ID: 21945444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constructing a better binding peptide for drug delivery targeting the interleukin-4 receptor.
    Bai XD; Cao XW; Chen YH; Fu LY; Zhao J; Wang FJ
    J Drug Target; 2020 Nov; 28(9):970-981. PubMed ID: 32363946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure, function, and targeting of interleukin 4 receptors on human head and neck cancer cells.
    Kawakami K; Leland P; Puri RK
    Cancer Res; 2000 Jun; 60(11):2981-7. PubMed ID: 10850446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A single replacement of histidine to arginine in EGFR-lytic hybrid peptide demonstrates the improved anticancer activity.
    Tada N; Horibe T; Haramoto M; Ohara K; Kohno M; Kawakami K
    Biochem Biophys Res Commun; 2011 Apr; 407(2):383-8. PubMed ID: 21396910
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of high affinity interleukin-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by interleukin-4.
    Obiri NI; Hillman GG; Haas GP; Sud S; Puri RK
    J Clin Invest; 1993 Jan; 91(1):88-93. PubMed ID: 8423237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel hybrid peptide targeting EGFR-expressing cancers.
    Kohno M; Horibe T; Haramoto M; Yano Y; Ohara K; Nakajima O; Matsuzaki K; Kawakami K
    Eur J Cancer; 2011 Mar; 47(5):773-83. PubMed ID: 21112771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A synthetic peptide corresponding to a critical intracellular signaling region of the human IL-4 receptor inhibits IL-4-induced proliferation.
    Izuhara K; Sakai M; Inaba R; Imamura T; Howard M; Harada N
    Cell Immunol; 1995 Jul; 163(2):254-9. PubMed ID: 7606796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of antilytic peptide antibody: application for the detection of lytic-based hybrid peptide in serum samples.
    Ohara K; Horibe T; Kohno M; Kawakami K
    J Pept Sci; 2011 Jul; 17(7):493-8. PubMed ID: 21351323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-4 receptor-targeted delivery of Bcl-xL siRNA sensitizes tumors to chemotherapy and inhibits tumor growth.
    Guruprasath P; Kim J; Gunassekaran GR; Chi L; Kim S; Park RW; Kim SH; Baek MC; Bae SM; Kim SY; Kim DK; Park IK; Kim WJ; Lee B
    Biomaterials; 2017 Oct; 142():101-111. PubMed ID: 28732245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and application of elastin like polypeptide containing IL-4 receptor targeting peptide.
    Sarangthem V; Cho EA; Bae SM; Singh TD; Kim SJ; Kim S; Jeon WB; Lee BH; Park RW
    PLoS One; 2013; 8(12):e81891. PubMed ID: 24339977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A review of studies on targeting interleukin 4 receptor for central nervous system malignancy.
    Puri S; Puri S; Mahapatra AK; Hussain E; Sarkar C; Sinha S; Joshi BH
    Curr Mol Med; 2009 Aug; 9(6):732-9. PubMed ID: 19689300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.